SCHEMBL21392685

SCHEMBL21392685

c1ccc(C2(c3ccccc3)c3ccccc3-c3ccc(N(c4ccc5c(c4)C4(c6ccccc6-c6ccccc64)c4ccccc4-5)c4ccc5c(c4)sc4ccccc45)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
GPR3 P46089 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
OPRK1 P41145 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDK2 Q15119 2/20 0.31
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20466627 0.99 MAPT (0.37) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL24883155 0.98 MAPT (0.35) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL25145517 0.96 MAPT (0.37) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL21559101 0.96 MAPT (0.34) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL21037305 0.96 MAPT (0.34) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL25145461 0.96 MAPT (0.37) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL25145377 0.95 MAPT (0.38) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL21141225 0.95 MAPT (0.35) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL21037566 0.94 ALDH1A1 (0.35) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL21392686 0.94 ALDH1A1 (0.41) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11877509-B2 Organic light-emitting element LG CHEM, LTD. 2024-01-16 US disclosed
US-11877509-B2 Organic light-emitting element LG CHEM, LTD. 2024-01-16 US disclosed
US-20230146354-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-05-11 US disclosed
US-20230146354-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-05-11 US disclosed
US-20230124044-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-04-20 US disclosed
US-20190296238-A1 Organic Light-emitting Element LG CHEM, LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296238-A1 Organic Light-emitting Element CRY1, CRY2, NR2E3 MAPT 665/4885SMN1; SMN2 2267/4885ALDH1A1 567/4885
US-11877509-B2 Organic light-emitting element CRY1, CRY2, NR2E3 MAPT 665/4885SMN1; SMN2 2267/4885ALDH1A1 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.